An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination

Vaccine

Volumn 12, Issue 11, 1994, Pages 993-999

  Cox, Rebecca J ^a   Brokstad, Karl A ^b   Zuckerman, Mark A ^a   Wood, John M ^c   Haaheim, Lars R ^b   Oxford, John S ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BERGEN   (Norway)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

ELISPOT; immune response; Influenza; vaccine

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VIRUS A; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS INACTIVATION;

ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMOLYTIC PLAQUE TECHNIQUE; HUMANS; IMMUNOGLOBULIN ISOTYPES; INFLUENZA VACCINES; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; VACCINES, INACTIVATED;

EID: 0028087674     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(94)90334-4     Document Type: Article

References (30)

1. The immune response to influenza vaccines
2. The systemic and mucosal immune response of humans to influenza A virus
3. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine
4. Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccines
5. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines
6. Improvement in immunoglobulin subclass response to influenza vaccine in elderly nursing home residents by the use of high dose vaccines
7. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response
8. Activity of influenza vaccine against virus strains now circulating
9. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine
10. A novel two-colour ELISPOT assay
11. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans
12. Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi
13. The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit
14. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies
15. Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin
16. Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice
17. The polypeptide composition of influenza A viruses
18. Quantitation and analysis of the specificity of post-immunisation antibodies to influenza B viruses using single radial haemolysis
19. Antibody response and persistence in volunteers following immunisation with varying dosages of a trivalent surface antigen influenza virus vaccine
20. The role of serum haemagglutination inhibition antibody in protection against challenge infection with influenza A and B viruses
21. A simple method of estimating fifty percent end points
22. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells
23. Kinetics of specific in vitro antibody production following influenza immunization
24. Passive transfer of local immunity to influenza virus infection by IgA antibody
25. IgA subclasses
26. The common mucosal immune system and current strategies for induction of immune responses in external secretions
27. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans
28. Comparative studies of the biological properties of human IgA subclasses